Q4 results today: PB Fintech, Dr Reddy's among 43 companies to announce results
Dr Reddy's and PB Fintech in the mix.
Other companies which will also announce the results include Bigbloc Construction, Century Textiles, Chambal Fertilisers, Graphite India, Hindustan Media, IDFC, Indraprastha Gas, Indo Euro Indchem, Infobeans Technologies, Jindal Saw, JSW Energy, Jupiter wagons among others.
Dr Reddy's Q4 expectations
Pharma major Dr Reddy's Laboratories is expected to post robust numbers in the fourth quarter ended March 2024, led by stable price erosion and improved US generic industry dynamics.
Revenue from operations in the January-March 2023 period is seen growing up to 18% year-on-year, according to an average estimate of four brokerages.
Meanwhile, net profit after tax (PAT) is likely to jump up to 54% year-on-year.
Analysts estimate the US sales growth to be strong at around 32% year-on-year to $412 million with strong traction likely in the existing portfolio and niche launches.
«We expect North America base business (ex-Revlimid) sales to grow 5% quarter-on-quarter to $310 million, led by volume ramp-up of products such as gSuboxone, gKuvan and gVascepa,» said Kotak Equities.
«Domestic revenue to grow 13% year-on-year on an India basis, adjusted for product divestment income of Rs 260 in Q4FY23. On the base in Q4FY23, Russia and PSAI business to be soft in Q4FY24. EBITDA margins expected to be 28.4%, 330bps year-on-year/40bps quarter-on-quarter,» said Nuvama.
PB Fintech
Despite a high base, a seasonally strong Q4 is expected to drive strong 18% year-on-year growth in core
